---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "FibriCheck US"
developer_entity: "Qompium"
bundle_id: "com.qompium.FibriCheck.us"
app_store_id: "6514316470"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-10-27"
report_date: "2026-08-18"
last_verified: "2026-08-18T00:00:00.000Z"
report_version: "2.14.0"
total_reviews: 1
overall_rating: 1
confidence: "low"
confidence_score: 0.3
data_age_days: 44
momentum_velocity: "zombie"
intelligence_version: 3
tags: ["medical", "paid", "mobile app", "app review", "app analysis", "patients", "diagnosed", "suspected"]
canonical_url: "https://marlvel.ai/apps/fibricheck-us"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# FibriCheck US Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Rating 1

> **TL;DR:** FibriCheck US is a medical app by Qompium, rated 1/5 by 1 users, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** FibriCheck US is a medical app by Qompium.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 1/5 (1 review) |
| **Category** | Medical |
| **Developer** | Qompium |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | Low (0.3/1.0) |
| **Data Age** | 44d |

## Metadata & Market Performance
- **Publisher:** Qompium
- **Category:** Medical
- **Target Audience:** Patients diagnosed with or suspected of having cardiac arrhythmias who require longitudinal monitoring under the guidance of a healthcare professional.
- **Platforms:** iOS
- **Version Reviewed:** 2.14.0
- **Report Date:** 2026-08-18
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.3/1.0)
- **App Store ID (iOS):** 6514316470
- **Bundle ID:** com.qompium.FibriCheck.us
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-18

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** FibriCheck US is a prescription-only medical device for smartphone-based heart rhythm assessment and clinical reporting.
**Why users hire it:** It replaces the need for external hardware in cardiac monitoring by utilizing the smartphone camera for clinical-grade rhythm data capture.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Smartphone-based PPG measurement:** Uses the smartphone camera to measure heart rhythm and rate in 60 seconds without external hardware.
  * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior.
- **[Differentiator] Clinical reporting:** Generates summarized rhythm strips and AF load data for physician review.
- **[Differentiator] EHR and platform integration:** API-based connectivity with existing electronic health records and population health systems.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

FibriCheck US operates in the regulated medical device space, where its clinical validation (FDA 510(k) K232804) serves as the primary differentiator against consumer-grade heart rate apps. The lack of recent updates (9 months) signals a maintenance-mode posture that leaves the app exposed to faster-moving wearable competitors.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** Prescription-only access
- **Analysis:** The app operates on a prescription-only model, requiring physician authorization to activate, which aligns with its status as a regulated medical device.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- FDA 510(k) clearance validates clinical rhythm monitoring mechanism
- EHR integration creates high switching costs for clinical partners

**Growth Levers:**
- Telehealth partnerships could expand the prescription activation funnel


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The report now explicitly anchors the app's competitive position to its FDA 510(k) clearance (K232804), moving from general clinical validation to specific regulatory status. Development remains in a maintenance-only state with no new feature releases.

**Overall trend**: Stable
**Compared at**: 2026-08-18

### High-impact changes
- **[Improved] Explicit FDA 510(k) Citation** (positioning)

### Medium-impact changes
- **[Added] Telehealth Partnership Opportunity** (swot)
- **[Shifted] Refined Threat Assessment** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v2.14.0, 9 months ago):** Maintenance update focused on minor improvements and bug fixes.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Quiet 9 months, no feature updates.
- Last major release October 2025.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 294 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

FibriCheck US is a medical app that is a paid app.
It holds a 1/5 rating from 1 review.

<!-- speakable-start -->
> **Bottom Line:** FibriCheck US relies on its clinical validation to maintain its position, but the 9-month update silence risks technical obsolescence. Prioritizing a maintenance release to ensure compatibility with the latest mobile operating systems would protect the existing clinical integration pipeline.
<!-- speakable-end -->

**Best for:** Patients diagnosed with or suspected of having cardiac arrhythmias who require longitudinal monitoring under the guidance of a healthcare professional.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [MAINTAIN] Ship a maintenance release to ensure OS compatibility because the app has been dormant for 9 months → prevent technical churn
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The medical device market is shifting toward integrated diagnostic tools that bridge the gap between patient-led monitoring and clinical EHR systems. FibriCheck US remains advantaged by its regulatory status, but the lack of recent development activity suggests the app is not currently capturing the growth potential of this shift.

- ⚪ The 9-month update silence indicates a maintenance-only posture, which limits the ability to respond to new mobile OS requirements.
- 🟢 FDA 510(k) clearance provides a defensible regulatory barrier that consumer wellness apps cannot easily replicate without significant clinical investment.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 1/5 |
| Total Reviews | 1 |
| Confidence | Low |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **FibriCheck US** (this app) | 1/5 | N/A | Qompium |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Qompium
- **Website:** [https://www.fibricheck.us/](https://www.fibricheck.us/)
- **Social:** [X/Twitter](https://twitter.com/fibricheck) · [LinkedIn](https://www.linkedin.com/company/qompium)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/fibricheck-us/id6514316470?uo=4)
- **Dev Site:** [Official Website](https://www.fibricheck.us/)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 44 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/fibricheck-us)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.